An injectable drug against HIV may be more promising than daily pills – News

PantherMediaSeller/DEPOSITPHOTOS

Injection therapy for HIV infection has been shown to be more effective than daily pills.

This was announced by the British drug manufacturer GSK, writes Reuters.

GSK has announced that an interim analysis of a late-stage study of a therapy known as Cabenuva, an injectable anti-HIV drug, has shown superior efficacy compared to taking a daily pill.

Cabenuva is a prescription drug that is used without any other antiviral drugs to treat HIV. The US Food and Drug Administration has approved Cabenuva for intramuscular use. It is the first approved once-monthly injectable full-course treatment for HIV-1-infected adults.

What is antiretroviral therapy for the treatment of HIV infection

Antiretroviral therapy (ART) is a system of treatment for people with HIV that helps minimize the impact of the disease on the body and prevents the virus from destroying the immune system.

The main task of antiretroviral therapy is to reduce the number of copies of viral particles in a milliliter of blood to an undetectable level – when the T-system no longer “sees” the virus in the patient’s blood test.

This is called the level of viral load in the body. And drugs – tablets or injections, reduce it to a minimum.

In Ukraine, HIV testing, examination and treatment are free of charge for the patient. All costs are fully covered by the state. The main thing that is required of a person is to adhere to the therapy scheme, that is, to take medication in a timely manner.

We will remind you that earlier we wrote about what to do if you are diagnosed with HIV.

And last year, a law came into effect in Ukraine, which changes the key principles of HIV testing and simplifies the access of HIV patients to medicines.